Abstract
Resistance to cisplatin [cis-diamminedichloroplatinum(II), CDDP] chemotherapy is a major problem in the clinic. Understanding the molecular basis of the intracellular accumulation of CDDP and other platinum-based anticancer drugs is of importance in delineating the mechanism of resistance to these clinically important therapies. Different molecular mechanisms may coexist, but defective uptake of CDDP is one of the most consistently identified characteristics of cells selected for CDDP resistance. We have studied the impact of intracellular chloride concentration on platinum-based compound accumulation in the human GLC4, GLC4/CDDP, and K562 tumor cell lines. We show that (1) a decrease of intracellular chloride concentration yielded an increase of CDDP accumulation and vice versa and (2) the intracellular chloride concentration in GLC4/CDDP cells is higher than in sensitive cells, whereas CDDP accumulation shows the opposite behavior. The identification of chloride as a critical determinant of CDDP intracellular accumulation and the molecular mechanisms by which CDDP-resistant cells modulate chloride concentration may allow alternative therapeutic approaches. Our findings indicate that increase of intracellular chloride concentration may be a major determinant of CDDP resistance.
Similar content being viewed by others
References
Brenner J, Magill GB, Sordillo PP, Cheng EW, Yagoda A (1982) Cancer 50:2031–2033
Rozencweig M, von Hoff DD, Slavik M, Muggia FM (1977) Ann Intern Med 86:803–812
Kartalou M, Essigmann JM (2001) Mutat Res 478:23–43
Wernyj RP, Morin PJ (2004) Drug Resist Update 7:227–232
Wang D, Lippard SJ (2005) Nat Rev Drug Discov 4:307–320
Kelland LR (2000) Drug Resist Update 3:139–141
Baird RD, Kaye SB (2003) Eur J Cancer 39:2450–2461
Oldenburg J, Begg AC, van Vugt MJ, Ruevekamp M, Schornagel JH, Pinedo HM, Los G (1994) Cancer Res 54:487–493
Andrews PA, Howell SB (1990) Cancer Cells 2:35–43
Gately DP, Howell SB (1993) Br J Cancer 67:1171–1176
Pereira-Maia E, Garnier-Suillerot A (2003) J Biol Inorg Chem 8:626–634
Lee EL, Shimizu T, Ise T, Numata T, Kohno K, Okada Y (2007) J Cell Physiol 211:513–521
Zijlstra JG, de Vries EG, Mulder NH (1987) Cancer Res 47:1780–1784
Hospers GA, Mulder NH, de Jong B, de Ley L, Uges DR, Fichtinger-Schepman AM, Scheper RJ, de Vries EG (1988) Cancer Res 48:6803–6807
Lozzio CB, Lozzio BB (1975) Blood 45:321–334
Lim MC, Martin RB (1976) J Inorg Nucl Chem 38:1911
Piwnica-Worms D, Jacob R, Horres CR, Lieberman M (1983) J Gen Physiol 81:731–748
Verkman AS, Sellers MC, Chao AC, Leung T, Ketcham R (1989) Anal Biochem 178:355–361
Garcia MA, Meizel S (1999) J Androl 20:88–93
El-Khateeb M, Appleton TG, Charles BG, Gahan LR (1999) J Pharm Sci 88:319–326
Dzamitika S, Salerno M, Pereira-Maia E, Le Moyec L, Garnier-Suillerot A (2006) J Bioenerg Biomembr 38:11–21
Chao AC, Dix JA, Sellers MC, Verkman AS (1989) Biophys J 56:1071–1081
Koncz C, Daugirdas JT (1994) Am J Physiol 267:H2114–H2123
Amorino GP, Fox MH (1996) J Membr Biol 152:217–222
Huang H, Zhu L, Reid BR, Drobny GP, Hopkins PB (1995) Science 270:1842–1845
Jiang S, Song MJ, Shin EC, Lee MO, Kim SJ, Park JH (1999) Hepatology 29:101–110
Wang D, Lippard SJ (2004) J Biol Chem 279:20622–20625
Berners-Price SJ, Ronconi L, Sadler PJ (2006) Prog Nucl Magn Reson Spectrosc 49:65–98
Kishimoto S, Kawazoe Y, Ikeno M, Saitoh M, Nakano Y, Nishi Y, Fukushima S, Takeuchi Y (2006) Cancer Chemother Pharmacol 57:84–90
Kalayda GV, Zhang G, Abraham T, Tanke HJ, Reedijk J (2005) J Med Chem 48:5191–5202
Miller SE, House DA (1989) Inorg Chim Acta 161:131–137
Berners-Price SJ, Apleton TG (2000) In: Kelland LR, Farrell NP (ed) Platinum-based drugs in cancer therapy. Humana Press, Totowa, pp 3–35
Reedijk J, Teuben JM (1999). In: Lippert B (ed) Cisplatin: chemistry and biochemistry of a leading anticancer drug. Wiley, Weinheim, pp 339–362
Bose RN, Ghosh SK, Moghaddas S (1997) J Inorg Biochem 65:199–205
Kelland L (2007) Nat Rev Cancer 7:573–584
Dabrowiak JC, Goodisman J, Souid AK (2002) Drug Metab Dispos 30:1378–1384
Berners-Price S, Kuchel PW (1990) J Inorg Biochem 38:327–345
Berners-Price S, Kuchel P (1990) J Inorg Chem 38:305–326
Ishikawa T, Ali-Osman F (1993) J Biol Chem 268:20116–20125
Arner ES, Nakamura H, Sasada T, Yodoi J, Holmgren A, Spyrou G (2001) Free Radic Biol Med 31:1170–1178
Jennerwein M, Andrews PA (1995) Drug Metab Dispos 23:178–184
Yarbrough JW, Merryman JI, Barnhill MA, Hahn KA (1999) In Vivo 13:375–383
Kawabe T, Chen ZS, Wada M, Uchiumi T, Ono M, Akiyama S, Kuwano M (1999) FEBS Lett 456:327–331
Nakayama K, Miyazaki K, Kanzaki A, Fukumoto M, Takebayashi Y (2001) Oncol Rep 8:1285–1287
Komatsu M, Sumizawa T, Mutoh M, Chen ZS, Terada K, Furukawa T, Yang XL, Gao H, Miura N, Sugiyama T, Akiyama S (2000) Cancer Res 60:1312–1316
Song IS, Savaraj N, Siddik ZH, Liu P, Wei Y, Wu CJ, Kuo MT (2004) Mol Cancer Ther 3:1543–1549
Beretta GL, Gatti L, Tinelli S, Corna E, Colangelo D, Zunino F, Perego P (2004) Biochem Pharmacol 68:283–291
Holzer AK, Samimi G, Katano K, Naerdemann W, Lin X, Safaei R, Howell SB (2004) Mol Pharmacol 66:817–823
Holzer AK, Katano K, Klomp LW, Howell SB (2004) Clin Cancer Res 10:6744–6749
Zisowsky J, Koegel S, Leyers S, Devarakonda K, Kassack MU, Osmak M, Jaehde U (2007) Biochem Pharmacol 73:298–307
Guo Y, Smith K, Petris MJ (2004) J Biol Chem 279:46393–46399
Owatari S, Akune S, Komatsu M, Ikeda R, Firth SD, Che XF, Yamamoto M, Tsujikawa K, Kitazono M, Ishizawa T, Takeuchi T, Aikou T, Mercer JF, Akiyama S, Furukawa T (2007) Cancer Res 67:4860–4868
Kabolizadeh P, Ryan J, Farrell N (2007) Biochem Pharmacol 73:1270–1279
Safaei R, Katano K, Samimi G, Naerdemann W, Stevenson JL, Rochdi M, Howell SB (2004) Cancer Chemother Pharmacol 53:239–246
Safaei R, Holzer A, Katano K, Samimi G, Howell S (2004) J Inorg Biochem 98:1607–1613
Beretta GL, Righetti SC, Lombardi L, Zunino F, Perego P (2002) Ultrastruct Pathol 26:331–334
Russell JM (2000) Physiol Rev 80:211–276
Acknowledgments
This research was supported by grants from Université Paris 13 and CNRS. We thank to Ricarda Riina for her help.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salerno, M., Yahia, D., Dzamitika, S. et al. Impact of intracellular chloride concentration on cisplatin accumulation in sensitive and resistant GLC4 cells. J Biol Inorg Chem 14, 123–132 (2009). https://doi.org/10.1007/s00775-008-0430-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-008-0430-3